Loading…
German private hospital operator running acute-care hospitals and university-affiliated clinics, majority owned by Asklepios.
German private hospital operator running acute-care hospitals and university-affiliated clinics, majority owned by Asklepios.
Paid per patient case under Germany's flat-rate system, set by insurers and state hospital planning, so margins depend on keeping costs under the fixed fees and filling beds. Governments pay for buildings and equipment; insurers pay running costs. The university hospital in Giessen and Marburg is a major site.
In one line: A German HCA Healthcare, smaller scale.
Moat: narrow (regulatory licence, scale, installed base). Licensed hospital capacity and academic-medicine partnerships, but reimbursement rates are government-regulated.
Headquarters: Bad Neustadt an der Saale, Germany · Founded: 1973 · Employees: 19,128
Size Rhon-klinikum (RHK.DE) is a Germany Health Care company (Hospital/Nursing Management) with a market value of $1.08B, the 141st largest of 205 Germany companies the cockpit tracks. Shares closed at €14.40 on 6 Nov 2026.
Performance Over six months the shares gained 14.3%, against -3.7% for the median peer and +2.6% for the Germany market (cap-weighted) — 5th highest of 20 in its peer set.
Growth Revenue grew 4.9% over the last twelve months (peer median +14.3%); the operating margin is 3.0% (peer median 10.3%).
Valuation It trades at 22.5× forward earnings against a peer median of 38.1× (5th cheapest of 16).
Capital Return on invested capital runs 2.4 points below its cost of capital (5.0% WACC).
Next results Next results expected around 1 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | €1.73B | €1.94B | €1.83B | €1.67B | €1.63B |
| Revenue growth | — | +6% | +9% | +2% | — |
| Gross profit | -€59.2M | €168M | €171M | €136M | €160M |
| EBITDA | €117M | €69.4M | €69.0M | €45.7M | €88.3M |
| Net income | €42.1M | €34.5M | €43.4M | €38.7M | €25.1M |
| Free cash flow | n/a | -€34.6M | €68.3M | €56.7M | -€15.7M |
| Capital expenditure | n/a | €99.1M | €70.4M | €62.8M | €58.2M |
| Total debt | €122M | €122M | €150M | €150M | €158M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Rhon-klinikum RHK.DE | $1.08B | +14% | +5% | 3% | 22.5× | n/a |
| Fresenius SE & Co. KGaA FRE.DE | $32.8B | +34% | +6% | 10% | 14.5× | 8.0% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | RHK.DE | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | 0.0% | -0.6% | 10th highest of 20 |
| 6-month return | +14.3% | -3.7% | 5th highest of 20 |
| Distance from 52-week high | -8.3% | -21.8% | 4th highest of 20 |
| Revenue growth (TTM) | +4.9% | +14.3% | 7th lowest of 21 |
| Operating margin | 3.0% | 10.3% | 3rd lowest of 20 |
| Forward P/E | 22.5× | 38.1× | 5th cheapest of 16 |
| ROIC minus cost of capital | -2.4 pp | -2.1 pp | 9th lowest of 20 |
| EV / EBITDA | 8.4× | 15.4× | 2nd cheapest of 16 |
| Net debt / EBITDA | -0.1× | 2.5× | 3rd least indebted of 17 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Rhon-klinikum RHK.DE | Germany | $1.08B | +14% | +5% | 3% | 22.5× | n/a | n/a |
| Ramsay Generale de Sante GDS.PA | France | $1.09B | -15% | +3% | 4% | n/a | 6.3% | +6.0% |
| Yatharth Hospital and Trauma Care Services YATHARTH.NS | India | $1.05B | +25% | +50% | 16% | 41.0× | n/a | n/a |
| Park Medi World PARKHOSPS.NS | India | $1.15B | +2% | +21% | n/a | 28.3× | 30.5% | +10.2% |
| Jupiter Life Line Hospitals JLHL.NS | India | $1,000M | +14% | +17% | 16% | 48.5× | n/a | n/a |
| Thomson Medical A50.SI | Singapore | $953M | -21% | +6% | 10% | n/a | 20.9% | +11.8% |
| CVS CVSG.L | United Kingdom | $1.23B | +20% | +6% | 11% | 14.3× | 13.7% | +6.9% |
| HealthCare Global Enterprises HCG.NS | India | $950M | -2% | +14% | 8% | 67.3× | n/a | n/a |
| Clinica Baviera CBAV.MC | Spain | $940M | -7% | +11% | 20% | 18.2× | 0.7% | +19.7% |
| Raffles Medical BSL.SI | Singapore | $1.25B | -15% | -3% | 11% | 27.3× | -2.4% | +6.1% |
| Rainbow Childrens Medicare RAINBOW.NS | India | $1.34B | -4% | +23% | 22% | 39.4× | 30.2% | +21.2% |
| Spire Healthcare SPI.L | United Kingdom | $1.34B | +68% | +2% | 8% | 19.5× | 9.8% | +11.4% |
| Paras Healthcare PARASHLTH.NS | India | $844M | n/a | +24% | 11% | n/a | n/a | n/a |
| Sanbo Hospital Management 301293.SZ | China | $1.48B | -21% | +17% | 6% | 148.9× | n/a | n/a |
| Aevis Victoria AEVS.SW | Switzerland | $1.49B | +9% | +15% | -6% | 107.9× | 26.6% | +10.2% |
| Xi'an International Medical Investment 000516.SZ | China | $1.54B | 0% | -1% | -2% | n/a | 13.6% | +20.6% |
| Sienna Senior Living SIA.TO | Canada | $1.63B | -11% | +16% | 10% | 38.1× | 19.6% | +8.6% |
| Kovai Medical Center & Hospital KOVAI.NS | India | $689M | +4% | +15% | 21% | n/a | 16.3% | +18.1% |
| Extendicare EXE.TO | Canada | $1.87B | -9% | +31% | 9% | 19.4× | 11.2% | +8.5% |
| Huaxia Eye Hospital 301267.SZ | China | $1.92B | -16% | +2% | 15% | 24.7× | 3.8% | +10.4% |
| Brookdale Senior Living BKD | United States | $2.15B | -31% | -4% | 5% | 127.7× | 22.4% | -1.4% |